Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cangrelor versus clopidogrel in acute coronary syndrome patients undergoing PCI
ACTRN12606000343505Phase 3Recruiting
- Sponsor
- The Medicines Company
- Start
- May 2006
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cangrelor and clopidogrel, sponsored by The Medicines Company. Started May 2006; status: recruiting.
02
Drugs
cangrelorclopidogrel
Beyond the preview
Go deeper on ACTRN12606000343505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000343505.